micro-community-banner
Profile Image
  • Saved
Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial

Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial

Source : https://www.jtcvs.org/article/S0022-5223(22)01243-0/fulltext

Right heart failure remains a serious complication of left ventricular assist device therapy. Many patients presenting for left ventricular assist device implantation have significant tricuspid regurgitation. It remains unknown whether...



Conclusions: The presence of significant tricuspid regurgitation before left ventricular assist device is associated with a high incidence of right heart failure within the first 6 months after surgery. Tricuspid valve surgery was successful in reducing postimplant tricuspid regurgitation compared with no tricuspid valve surgery but was not...

Profile Image
  • Saved
Multiple Prior Live Births are Associated with Cardiac Remodeling and Heart Failure Risk in Women

Multiple Prior Live Births are Associated with Cardiac Remodeling and Heart Failure Risk in Women

Source : https://www.onlinejcf.com/article/S1071-9164(23)00004-0/fulltext

Pregnancy presents a window of opportunity to identify those who may be at greater long-term cardiovascular risk, both because this is a unique time-period when they are highly engaged in...



Conclusions: Greater number of live births are associated with worse cardiac structure and function. While there was no association with overall HF, a higher number of live births was associated with greater risk for incident HFrEF.

Profile Image
  • Saved
A fast computational model for circulatory dynamics: effects of left ventricle-aorta coupling - Biomechanics and Modeling in Mechanobiology

A fast computational model for circulatory dynamics: effects of left ventricle-aorta coupling - Biomechanics and Modeling in Mechanobiology

Source : https://link.springer.com/article/10.1007/s10237-023-01690-w

The course of diseases such as hypertension, systolic heart failure and heart failure with a preserved ejection fraction is affected by interactions between the left ventricle (LV) and the vasculature....



Conclusion: A novel circulatory system model is presented, using a combination of spatially resolved and lumped-parameter component representations, which allows simulations of multiple cardiac cycles with computations that run faster than real time. The model is applied to examine the consequences of the aortic stiffening that occurs with...

Profile Image
  • Saved
Blood pressure in heart failure management and prevention - Hypertension Research

Blood pressure in heart failure management and prevention - Hypertension Research

Source : https://www.nature.com/articles/s41440-022-01158-x

Comparison between patients with and without heart failure regarding blood pressure The association between CV events and SBP is linear in patients without heart failure; however, it becomes J-shaped or...



Conclusions/Relevance: This review discusses the potential mechanisms by which hypertension leads to HFrEF or HFpEF, the impact of hypertension on incident heart failure, and the recommended approaches for blood pressure management in patients with heart failure.

Profile Image
  • Saved
Entrectinib-Induced Heart Failure in a Patient With Metastatic Lung Adenocarcinoma: A Case Report

Entrectinib-Induced Heart Failure in a Patient With Metastatic Lung Adenocarcinoma: A Case Report

Source : https://www.cureus.com/articles/115635-entrectinib-induced-heart-failure-in-a-patient-with-metastatic-lung-adenocarcinoma-a-case-report

Entrectinib is a recently approved multikinase inhibitor to treat advanced c-ros oncogene1 (ROS1) positive non-small cell lung cancer (NSCLC). Although molecular targeted therapy is generally well tolerated, cardiovascular adverse events...



Conclusions: We presented a case of symptomatic CTRCD after entrectinib treatment in a patient with ROS1-rearranged metastatic lung adenocarcinoma. Physicians should monitor cardiac function as patients may develop heart failure, especially in the early phase of entrectinib initiation. The number of cases where entrectinib is prescribed is...

Profile Image